Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated.
Jessica R AllegrettiAndrew CanakisEmma McClureJenna MarcusBeth-Ann NortonMatthew J HamiltonRachel W WinterPunyanganie S De SilvaSonia FriedmanJoshua R KorzenikPublished in: Inflammatory bowel diseases (2022)